RevOpsis Therapeutics
PrivateLast Round
VC Round
Sep 16, 2025
Total Funding Raised
$18.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
RevOpsis Therapeutics is a biopharmaceutical company that develops multispecific antibody treatments for complex diseases, with an initial focus on retinal vascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RevOpsis Therapeutics Comparables
Compare RevOpsis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tavo Biotherapeutics | 84% | |
| AsclepiX Therapeutics | 83% | |
| INGENIA Therapeutics | 82% |
RevOpsis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 16, 2025 | ||||
| Grant | Oct 15, 2024 | ||||
| Seed | Apr 25, 2024 |
RevOpsis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Eye Institute (NIH) | Grant |
| NIH RADx | Grant |
| National Eye Institute | Grant |
| ExSight Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 134% MoM, reaching 1.5K.
- Apr 21, 2026
Monthly visitors grew 351% MoM, from 227 to 1K.
RevOpsis Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about RevOpsis Therapeutics's valuation, stock price, and market status.
Is RevOpsis Therapeutics a public or private company?
RevOpsis Therapeutics is a private company.
What is the current stock price of RevOpsis Therapeutics?
RevOpsis Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is RevOpsis Therapeutics worth (valuation)?
Valuation information for RevOpsis Therapeutics is not publicly available.
Can I buy RevOpsis Therapeutics stock?
RevOpsis Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was RevOpsis Therapeutics's last funding round?
RevOpsis Therapeutics's most recent funding round was VC Round on September 16, 2025.
Who are the main investors in RevOpsis Therapeutics?
Key investors in RevOpsis Therapeutics include ExSight Ventures.
Will RevOpsis Therapeutics IPO soon?
No public IPO plans have been announced for RevOpsis Therapeutics.
How can I track RevOpsis Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RevOpsis Therapeutics's secondary market activity and sign up for updates.